We are live on ! Find out more

OMDA

Omada Health Inc

OMDA

Market cap $1.32B

21.50 USD

-0.68

3.07%

At close Updated Sep 9, 4:00 PM EDT

Pre-market

After hours

21.50

0.00

0%

1 day

-3.07%

5 days

-6.52%

1 month

-13.97%

3 months

17.36%

6 months

49.41%

Year to date

44.3%

1 year

-8.51%

5 years

-6.52%

10 years

-6.52%

About: Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor's visits. The integrated platform of the company supports members with cardiometabolic conditions like prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health needs. The company's specialized care tracks also assist members using GLP-1 medications. The company delivers measurable health outcomes and value for employers, health plans, health systems, and pharmacy benefit managers.

Employees: 946

Healthcare Health Information Services

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 44.4%

Neutral 55.6%

Negative 0%

Independent Model Estimates Up To $11,142 in Gross Medical Cost Savings Per Member Over Five Years for Omada's GLP-1 Program

SAN FRANCISCO, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual-first, between-visit healthcare provider, announced a new, independent cost savings model that examined the measurable clinical and economic value of Omada's GLP-1 program.1 GlobalData , a data analytics and consulting company, recently published a report estimating greater disease reduction and higher cumulative cost savings with Omada's GLP-1 solutions compared to standard care.

Independent Model Estimates Up To $11,142 in Gross Medical Cost Savings Per Member Over Five Years for Omada's GLP-1 Program

The Motley Fool

Insider Alert: Omada Health CEO Sean Duffy Sells 31,457 Shares

Traded 31,457 shares with a transaction value of ~$735,150 based on a weighted average price of $23.37 per share. The activity involved shares equal to 2% of the total equity stake held before the filing, including direct transactions equal to 8% of the prior direct position.

Insider Alert: Omada Health CEO Sean Duffy Sells 31,457 Shares

Omada Health: Q2 Shows More Evidence Of Growth Converting Into Earnings

Omada Health (OMDA) delivered strong Q2 results, with 43% revenue growth, margin expansion, and positive adj. EBITDA, reinforcing my buy rating. OMDA's product expansion, especially in diabetes and hypertension, is driving higher revenue per member and improving customer-lifetime-value through multi-program adoption. Channel partnerships with PBMs and health plans are lowering CAC, supporting scalable growth and better unit economics, while AI initiatives further enhance operational leverage.

Omada Health: Q2 Shows More Evidence Of Growth Converting Into Earnings

Omada Health Touts Record Q2 as GLP-1 Demand Fuels Growth Strategy

Omada Health NASDAQ: OMDA highlighted record second-quarter revenue and margin performance at the Canaccord Genuity Growth Conference, while outlining its strategy to expand across cardiometabolic conditions, deepen channel partnerships and use GLP-1-related demand to broaden customer relationships.

Omada Health Touts Record Q2 as GLP-1 Demand Fuels Growth Strategy

Zacks Investment Research

Omada Health, Inc. (OMDA) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Omada Health, Inc. (OMDA) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Omada Health, Inc. (OMDA) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Omada Health, Inc. (OMDA) Q2 2026 Earnings Call Transcript

Omada Health, Inc. (OMDA) Q2 2026 Earnings Call Transcript

Omada Health, Inc. (OMDA) Q2 2026 Earnings Call Transcript

Omada Health Q2 Earnings Call Highlights

Omada Health NASDAQ: OMDA reported record second-quarter results for 2026, citing broad-based growth across its cardiometabolic programs, expanding channel partnerships and lower costs to serve members. The company also announced that President Wei-Li Shao will succeed Co-founder and Chief Executive Officer Sean Duffy as CEO on Jan. 1, 2027.

Omada Health Q2 Earnings Call Highlights

Zacks Investment Research

Omada Health, Inc. (OMDA) Q2 Earnings and Revenues Top Estimates

Omada Health, Inc. (OMDA) came out with quarterly earnings of $0.15 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to a loss of $0.09 per share a year ago.

Omada Health, Inc. (OMDA) Q2 Earnings and Revenues Top Estimates

Omada Health Reports Second Quarter 2026 Results and Announces CEO Transition

Revenue Grew 43% and Total Members Increased 45% Year over Year, with Gross Margin Reaching a New Quarterly Record Company Announces Sean Duffy to Become Executive Chair and Wei-Li Shao to Become Chief Executive Officer on January 1, 2027 SAN FRANCISCO, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Omada Health, Inc. (Nasdaq: OMDA), the virtual between-visit healthcare provider, today reported financial results for the second quarter ended June 30, 2026. Omada Health also announced co-founder and CEO Sean Duffy will transition to Founder and Executive Chair effective January 1, 2027, with President Wei-Li Shao assuming the role of CEO.

Omada Health Reports Second Quarter 2026 Results and Announces CEO Transition

UPDATE - Omada Health to Announce Second Quarter 2026 Financial Results and Host Conference Call on August 6, 2026

SAN FRANCISCO, July 23, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that it will release its second quarter 2026 results on Thursday, August 6, 2026, after market close, and host a conference call to review the results at 4:30 pm ET the same day. Conference Call Details A live audio webcast of the call will be available online at https://investors.omadahealth.com.

UPDATE - Omada Health to Announce Second Quarter 2026 Financial Results and Host Conference Call on August 6, 2026

See News Rankings

Price charts implemented using Lightweight Charts™